Equinix Inc (EQIX)vsEUDA Health Holdings Limited (EUDA)
EQIX
Equinix Inc
$1,008.02
-2.59%
REAL ESTATE · Cap: $101.46B
EUDA
EUDA Health Holdings Limited
$20.35
+2.26%
REAL ESTATE · Cap: $44.88M
Smart Verdict
WallStSmart Research — data-driven comparison
Equinix Inc generates 139571% more annual revenue ($9.53B vs $6.82M). EQIX leads profitability with a 14.9% profit margin vs -40.7%. EQIX earns a higher WallStSmart Score of 54/100 (C-).
EQIX
Buy54
out of 100
Grade: C-
EUDA
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-86.5%
Fair Value
$561.23
Current Price
$1008.02
$446.79 premium
Intrinsic value data unavailable for EUDA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 24.3%
Earnings expanding 20.0% YoY
Revenue surging 78.9% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Elevated debt levels
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : EQIX
The strongest argument for EQIX centers on Market Cap, Operating Margin, EPS Growth. Revenue growth of 12.1% demonstrates continued momentum.
Bull Case : EUDA
The strongest argument for EUDA centers on Revenue Growth, Debt/Equity. Revenue growth of 78.9% demonstrates continued momentum.
Bear Case : EQIX
The primary concerns for EQIX are Debt/Equity, Piotroski F-Score, PEG Ratio. A P/E of 71.0x leaves little room for execution misses. Debt-to-equity of 1.63 is elevated, increasing financial risk.
Bear Case : EUDA
The primary concerns for EUDA are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
EQIX profiles as a value stock while EUDA is a hypergrowth play — different risk/reward profiles.
EQIX carries more volatility with a beta of 0.97 — expect wider price swings.
EUDA is growing revenue faster at 78.9% — sustainability is the question.
EUDA generates stronger free cash flow (-632,577), providing more financial flexibility.
Bottom Line
EQIX scores higher overall (54/100 vs 24/100) and 12.1% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Equinix Inc
REAL ESTATE · REIT - SPECIALTY · USA
Equinix, Inc. is an American multinational company headquartered in Redwood City, California, that specializes in Internet connection and data centers.
Visit Website →EUDA Health Holdings Limited
REAL ESTATE · REAL ESTATE SERVICES · USA
EUDA Health Holdings Limited is a forward-looking biopharmaceutical company focused on innovating treatments for rare diseases and addressing unmet medical needs. Leveraging advanced technologies, the firm is developing a robust clinical pipeline with a particular emphasis on supportive care and immune modulation. EUDA's strong commitment to research and development positions it favorably in the healthcare landscape, aiming to enhance patient outcomes and expand access to crucial therapies.
Visit Website →Compare with Other REIT - SPECIALTY Stocks
Want to dig deeper into these stocks?